Literature DB >> 7433917

Central nervous system manifestations associated with serologically verified Mycoplasma pneumoniae infection.

A Pönkä.   

Abstract

Among 560 hospitalized patients with serologically verified Mycoplasma pneumoniae infection (significant titre rise of complement-fixing antibodies in paired sera), 27 (4.8%) had central nervous system (CNS) manifestations for which no evidence incriminating any other causal agent could be found. Of these patients 18 had encephalitis or meningoencephalitis, 8 aseptic meningitis and 1 polyradiculitis. Of the patients with meningoencephalitis 4 died and 3 had permanent sequelae. The cases of aseptic meningitis were benign without any deaths or sequelae. There was a predominance of young age groups, 13 patients (48%) being below 10 years of age. Neither erythromycin nor tetracycline had a beneficial effect on the course of the illness in a few patients treated. Another 15 patients had CNS manifestations for which an alternative aetiology was suspected. The specificity of the M. pneumoniae CF test in the diagnostics of CNS manifestations is discussed, as well as the pathogenesis of the CNS complications associated with M. pneumoniae infection. Some features are summarized from 87 case reports presented earlier in the literature.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7433917     DOI: 10.3109/inf.1980.12.issue-3.04

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  15 in total

Review 1.  Methyl-prednisolone in neurologic complications of Mycoplasma pneumonia.

Authors:  K Gücüyener; F Simşek; O Yilmaz; A Serdaroğlu
Journal:  Indian J Pediatr       Date:  2000-06       Impact factor: 1.967

2.  Central nervous system involvement by Mycoplasma pneumoniae.

Authors:  M Narita
Journal:  Clin Mol Pathol       Date:  1995-08

3.  Bilateral optic neuropathy and white dot syndrome following a mycoplasmal infection.

Authors:  M Cordonnier; L E Caspers-Velu; C Jacquemin; C Van Nechel; M Tombroff
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

4.  Polyradiculitis associated with Mycoplasma pneumoniae reversed by plasma exchange.

Authors:  A Pönkä; M von Bonsdorff; M Färkkilä
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05

Review 5.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Mycoplasma pneumoniae-induced hydrocephalus in hamsters.

Authors:  D F Kohn; N Chinookoswong; J Wang
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

7.  Anticentriolar autoantibodies in children with central nervous system manifestations of Mycoplasma pneumoniae infection.

Authors:  N Cimolai; D Mah; E Roland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

8.  [Fulminant meningoencephalitis associated with Mycoplasma pneumoniae infection in adults. Aggressive treatment enabled a good outcome].

Authors:  Roland Sparing; Christoph Spitzer; Helga Häfner; Dirk Zolldann; Marcus H T Reinges; Timo Krings; Johannes Noth; Christoph M Kosinski
Journal:  Nervenarzt       Date:  2004-10       Impact factor: 1.214

9.  [Atypical encephalitis in a 20-year-old soldier].

Authors:  O Lanczik; O Lecei; S Schwarz; S Pfleger; K-P Becker; M Hennerici
Journal:  Nervenarzt       Date:  2004-02       Impact factor: 1.214

Review 10.  Mycoplasma pneumoniae: nervous system complications in childhood and review of the literature.

Authors:  Uluç Yiş; Semra Hiz Kurul; Handan Cakmakçi; Eray Dirik
Journal:  Eur J Pediatr       Date:  2008-05-28       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.